Clearside Biomedical Inc (NAS:CLSD)
$ 1.305 -0.005 (-0.38%) Market Cap: 97.54 Mil Enterprise Value: 69.42 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Q2 2020 Clearside Biomedical Inc Earnings Call Transcript

Aug 10, 2020 / 08:30PM GMT
Release Date Price: $1.79 (+1.70%)
Operator

Good afternoon, ladies and gentlemen and welcome to the Clearside Biomedical Second Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, speaker, Jenny Kobin, Investor Relations for Clearside. Please go ahead, madam.

Jenny R. Kobin
Clearside Biomedical, Inc. - Head of IR

Good afternoon, everyone and thank you for joining us on the call today. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call about the company's future expectations, plans and prospects, constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our annual report on Form 10-K for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot